Scott Stromatt, EVP, Clinical Development & Reg Affair at CELL THERAPEUTICS INC (CTIC), sold 20,000 shares at $1.39 ($28K) on 2006-06-20, disclosed to the SEC on 2006-06-22.
Scheduled sale ($28k) by EVP, Clinical Development & Reg Affair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 10,000 | $14K | 49.8% |
| 2 | $1.40 | 10,000 | $14K | 50.2% |
| Total | $1.40 avg | 20,000 | $28K | 100% |
| Filing → |
| CTIC | SELL | 2006-12-15 | $14K | — | Filing → |
| CTIC | SELL | 2006-09-01 | $4K | — | Filing → |